Welcome to the Emerging Pathogens & Infectious Diseases Consortium
Welcome to EPIC – the Emerging Pathogens and Infectious Diseases Consortium.
EPIC brings together researchers, clinicians, and institutions across the University of Toronto and its hospital partners to advance infectious disease research and build lasting resilience against emerging threats.
This work builds on a long legacy: EPIC partners have played an integral role in infectious disease research for a century, from work that helped control diphtheria and eradicate smallpox, to today’s front-line research in antimicrobial resistance and infection control. Our collective response to COVID-19, highly pathogenic avian influenza, and mpox makes clear there’s never been a more important time to advance that work, from emerging pathogens and antimicrobial resistance to health inequities and public trust.
Building on this momentum, EPIC marshals the advanced research infrastructure and world-renowned research and training expertise of our EPIC partners to deliver an integrated, innovative response to the infectious disease challenges facing communities today and in the future.
Seven EPIC research clusters
Antimicrobial Resistance
Protecting the effectiveness of the medicines we depend on.
Chronic Infections
Addressing the long-term burden of infections that don’t resolve.
Emerging Pathogens
Detecting and responding to new and re-emerging threats before they spread.
Health Inequities
Ensuring infectious disease research and response reach everyone, equitably.
Health Systems Resilience
Building health systems that bend, not break, under infectious threats.
Misinformation, Disinformation & Public Trust
Strengthening public trust through clear, credible information.
Sepsis & Acute Respiratory Distress
Improving detection and treatment when every minute counts.
EPIC News
Second annual symposium on antimicrobial resistance highlights opportunities and challenges to tackling AMR
December 7, 2023 By Betty Zou The Emerging and Pandemic Infections Consortium, along with partners bioMérieux Canada, the AMR – One Health Consortium and the Association of Medical Microbiology and Infectious Disease Canada (AMMI Canada), recently co-hosted the second...
World AIDS Day: How EPIC researchers are advancing new treatment strategies and supporting older adults with HIV
Subha Dahal (left) and Alice Zhabokritsky December 1, 2023 By Betty Zou Over four decades after the start of the AIDS epidemic, researchers in the Emerging and Pandemic Infections Consortium are reshaping approaches to target the human immunodeficiency virus (HIV)...
Toronto infectious disease community tackles antimicrobial resistance from multiple angles
(Photo by Roberto Sorin on Unsplash) November 23, 2023 By Betty Zou Earlier this year, the federal government released its Pan-Canadian Action Plan on Antimicrobial Resistance, which details federal, provincial and territorial commitments to address antimicrobial...
